| Popis: |
The Gastric cancer (GC) is the third deadliest malignant disease worldwide. The most common conventional therapies include the use of anticancer drugs; however, their use is ineffective and is limited due to the poor solubility of the drug and its ability to damage the immune system, since anticancer drugs have a small therapeutic drug, overdosing can lead to the toxicity in the systemic organs such as lung, liver and kidneys. Nanotechnology, which has been developed about a decade ago is considered to be a more advantageous therapy compared to the conventional methods for the therapy of cancers like GC. Varied type of nanoparticles that are multifunctional are now used to enhance the solubility and effectiveness of the drug for the treatment, prevention and diagnosis with the annual clinical trials. Moreover, they are biocompatible and less toxic to the normal healthy cells. The organic and inorganic nanoparticles that are used in the cancer diagnosis and drug delivery system include lipid, protein, metal and polymer-based materials. This chapter gives an overview on the types of nanoparticle used in the research for the GC therapy. Additionally, we have briefly described the combinational approaches, including gene therapy and immunotherapy, along with nanoparticles that includes antibody mediated, enzyme and ligand mediated strategies. |
